Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Marysville
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Marysville, WA

Studies commonly pay $75 to $4,500 per completed study

198 clinical trials are currently recruiting participants within 30 miles of Marysville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

198studies recruiting
7+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Marysville right now

Top 25 of 198 recruiting studies, sorted by proximity — each links to its official registry page

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm N/A Observational 5,000 participants sought
Virginia Mason Lynnwood Medical Center — Lynnwood, Washington (19.4 mi) · Sponsor: National Cancer Institute LAO
See eligibility & contact on ClinicalTrials.gov (NCT02474160)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

Comparative Self-collection for Cervical Cancer Screening Pivotal Study

HPV, HPV - Anogenital Human Papilloma Virus Infection N/A Interventional 260 participants sought
National Eagle Research — Lynnwood, Washington (19.4 mi) · Sponsor: Mel Mont Medical
See eligibility & contact on ClinicalTrials.gov (NCT07758140)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06126276)

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer Phase 3 Interventional 480 participants sought
Swedish Cancer Institute — Edmonds, Washington (21.3 mi) · Sponsor: ArriVent BioPharma, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07185997)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07200830)

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Colorectal Neoplasms Phase 3 Interventional 1,000 participants sought
Swedish Cancer Institute Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06662786)

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar I Disorder, Bipolar II Disorder Phase 2 Interventional 195 participants sought
Core Clinical Research /ID# 272955 — Everett, Washington (7.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06696755)

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Bipolar Disorder, Bipolar Depression Phase 3 Interventional 400 participants sought
Core Clinical Research — Everett, Washington (7.4 mi) · Sponsor: Xenon Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07172516)

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Carcinoma, Non-small-Cell Lung Phase 2 Interventional 520 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT05498428)

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Parkinson Disease Phase 2 Interventional 150 participants sought
EvergreenHealth (Site #219) — Kirkland, Washington (27.7 mi) · Sponsor: Appello Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07432958)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04871542)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
Frontier Dermatology — Mill Creek, Washington (15.4 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Type 2 Diabetes Phase 2 Interventional 200 participants sought
Eastside Research Associates — Redmond, Washington (28.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06897475)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
Swedish Cancer Institute - Edmonds Campus — Edmonds, Washington (21.3 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06246916)

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

Sjögren's Syndrome Phase 3 Interventional 844 participants sought
Western Washington Medical Group, Bothell - Rheumatology — Bothell, Washington (22.1 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT06747949)

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 335 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05554406)

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Depressive Disorder, Major Phase 3 Interventional 752 participants sought
Core Clinical Research — Everett, Washington (7.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06559306)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Major Depressive Disorder (MDD), Depression in Adults Phase 3 Interventional 330 participants sought
Core Clinical Research — Everett, Washington (7.4 mi) · Sponsor: Cybin IRL Limited
See eligibility & contact on ClinicalTrials.gov (NCT06793397)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT03150693)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Atopic Dermatitis N/A Observational 1,000 participants sought
Frontier Dermatology Partners CRO LLC- Site Number : 8400011 — Mill Creek, Washington (15.4 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07290803)
Actively enrolling

Studies you may be able to join near Marysville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Marysville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Core Clinical Research

★ 4.2
2918 Colby Ave, Everett, WA 98201
(425) 443-9551
"I appreciate everyone on the team here, the staff was very kind and welcoming, quiet environment. Very thorough process, but pretty easy!"
— Drake Thompson, 5★

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Providence Everett Center for Clinical Research

★ 1.0
1330 Rockefeller Ave Ste 440, Everett, WA 98201
(425) 261-4069

Clinical Research: Western Washington Medical Group

★ 5.0
12728 19th Ave SE Ste 300, Everett, WA 98208
(425) 225-2760

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

Clinical Research Center at Minor

★ 4.7
820 Minor Ave N, Seattle, WA 98109
(206) 667-7100
"Wonderful staff, supportive environment"
— Susan Mausshardt, 5★

Clinical trials in Marysville: what's recruiting

The Marysville area currently has 198 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Marysville, the most active research areas are:

  • Cancer & Oncology9 studies
  • Brain & Mental Health5 studies
  • Diabetes & Metabolism2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Marysville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Marysville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Marysville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Marysville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Marysville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Marysville, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Marysville typically complete one or two studies per year.

Paid clinical trials near Marysville

Other metros within reach

Bellevue, WA1,509 Seattle, WA1,501 Bremerton, WA1,475 Tacoma, WA1,453 Olympia, WA226 Vancouver, WA1,020 Portland, OR1,020 Salem, OR112

By condition

Eligibility and exclusions, condition by condition

MASH (cirrhosis due to MASH) in Marysville Bladder Issues Due To Spinal Cord Injury in Marysville All conditions

More of WA

Bellevue1,509 Seattle1,501 Bremerton1,475 Tacoma1,453 Vancouver1,020 Spokane294 Olympia226 Kennewick54

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts